|
1
|
Ames H, Halushka MK and Rodriguez FJ:
miRNA regulation in gliomas: Usual suspects in glial tumorigenesis
and evolving clinical applications. J Neuropathol Exp Neurol.
76:246–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cives M, Ghayouri M, Morse B, Brelsford M,
Black M, Rizzo A, Meeker A and Strosberg J: Analysis of potential
response predictors to capecitabine/temozolomide in metastatic
pancreatic neuroendocrine tumors. Endocr Relat Cancer. 23:759–767.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dilillo M, Ait-Belkacem R, Esteve C,
Pellegrini D, Nicolardi S, Costa M, Vannini E, Graaf EL, Caleo M
and McDonnell LA: Ultra-high mass resolution MALDI imaging mass
spectrometry of proteins and metabolites in a mouse model of
glioblastoma. Sci Rep. 7:6032017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Piano V, Benjamin DI, Valente S, Nenci S,
Marrocco B, Mai A, Aliverti A, Nomura DK and Mattevi A: Discovery
of inhibitors for the ether lipid-generating enzyme AGPS as
anti-cancer agents. ACS Chem Biol. 10:2589–2597. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu Y, Liu XJ, Yang P, Zhao M, Lv LX,
Zhang GD, Wang Q and Zhang L: Alkylglyceronephosphate synthase
(AGPS) alters lipid signaling pathways and supports chemotherapy
resistance of glioma and hepatic carcinoma cell lines. Asian Pac J
Cancer Prev. 15:3219–3226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Y, Liu A, Zhang X, Qi L, Zhang L, Xue
J, Liu Y and Yang P: The effect of benzyl isothiocyanate and its
computer-aided design derivants targeting alkylglycerone phosphate
synthase on the inhibition of human glioma U87MG cell line. Tumour
Biol. 36:3499–3509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Razeto A, Mattiroli F, Carpanelli E,
Aliverti A, Pandini V, Coda A and Mattevi A: The crucial step in
ether phospholipid biosynthesis: Structural basis of a noncanonical
reaction associated with a peroxisomal disorder. Structure.
15:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu Y, Zhu L, Lu L, Zhang L, Zhang G, Wang
Q and Yang P: Role and mechanism of the alkylglycerone phosphate
synthase in suppressing the invasion potential of human glioma and
hepatic carcinoma cells in vitro. Oncol Rep. 32:431–436. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Battu MB, Chandra AM, Sriram D and
Yogeeswari P: Pharmacophore-based 3DQSAR and molecular docking
studies to identify new non-peptidic inhibitors of cathepsin S.
Curr Med Chem. 21:1910–1921. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Verma SK and Thareja S: Structure based
comprehensive modelling, spatial fingerprints mapping and ADME
screening of curcumin analogues as novel ALR2 inhibitors. PLoS One.
12:e01753182017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Silginer M, Weller M, Stupp R and Roth P:
Biological activity of tumor-treating fields in preclinical glioma
models. Cell Death Dis. 8:e27532017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin CY and Huang HM: Unilateral malignant
optic glioma following glioblastoma multiforme in the young: A case
report and literature review. BMC Ophthalmol. 17:212017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Louis DN, Perry A, Reifenberger G, et al:
The 2016 World Health Organization classification of tumors of the
central nervous system: A summary. Acta Neuropathol. 131:803–820.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang N, Zhang Q, Ning B, Luo L and Fang Y:
β-Asarone promotes Temozolomide's entry into glioma cells and
decreases the expression of P-glycoprotein and MDR1. Biomed
Pharmacother. 90:368–374. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Holdhoff M, Ye X, Supko JG, Nabors LB,
Desai AS, Walbert T, Lesser GJ, Read WL, Lieberman FS, Lodge MA, et
al: Timed sequential therapy of the selective T-type calcium
channel blocker mibefradil and temozolomide in patients with
recurrent high-grade gliomas. Neuro Oncol. 19:845–852. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai Z, Zhang G, Zhang X, Liu Y and Fu X:
Current insights into computer-aided immunotherapeutic design
strategies. Int J Immunopathol Pharmacol. 28:278–285. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Medeiros Turra K, Pineda Rivelli D,
Berlanga de Moraes Barros S and Mesquita Pasqualoto KF:
Constructing and validating 3D-pharmacophore models to a set of
MMP-9 inhibitors for designing novel anti-melanoma agents. Mol
Inform. 35:238–252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Valasani KR, Chaney MO, Day VW and Shidu
Yan S: Acetylcholinesterase inhibitors: Structure based design,
synthesis, pharmacophore modeling, and virtual screening. J Chem
Inf Model. 53:2033–2046. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cao D, Wang J, Zhou R, Li Y, Yu H and Hou
T: ADMET evaluation in drug discovery. 11. PharmacoKinetics
Knowledge Base (PKKB): A comprehensive database of pharmacokinetic
and toxic properties for drugs. J Chem Inf Model. 52:1132–1137.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gomeni R, Bani M, D'Angeli C, Corsi M and
Bye A: Computer-assisted drug development (CADD): An emerging
technology for designing first-time-in-man and proof-of-concept
studies from preclinical experiments. Eur J Pharm Sci. 13:261–270.
2001. View Article : Google Scholar : PubMed/NCBI
|
